| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8722732 | HPB | 2018 | 9 Pages |
Abstract
While neoadjuvant therapy is associated with decreased R1/R2-resection rates after pancreaticoduodenectomy, the poor prognostic impact of positive margins is not abrogated by neoadjuvant therapy, stressing the need for complete tumor clearance and postoperative treatment even after neoadjuvant therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Susanna W.L. de Geus, Gyulnara G. Kasumova, Teviah E. Sachs, Sing Chau Ng, Tara S. Kent, A. James Moser, Alexander L. Vahrmeijer, Mark P. Callery, Jennifer F. Tseng,